Pantheon Resources PLC
LSE:PANR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pantheon Resources PLC
LSE:PANR
|
UK |
|
HKR International Ltd
HKEX:480
|
HK |
|
Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO
|
IN |
|
Atomera Inc
NASDAQ:ATOM
|
US |
|
Leeport (Holdings) Ltd
HKEX:387
|
HK |
|
China Nuclear Engineering & Construction Corp Ltd
SSE:601611
|
CN |
|
Hubbell Inc
NYSE:HUBB
|
US |
Balance Sheet
Balance Sheet Decomposition
Pantheon Resources PLC
Pantheon Resources PLC
Balance Sheet
Pantheon Resources PLC
| Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
16
|
3
|
6
|
0
|
6
|
4
|
3
|
2
|
1
|
7
|
24
|
4
|
3
|
2
|
5
|
6
|
58
|
21
|
8
|
13
|
|
| Cash |
15
|
3
|
6
|
0
|
6
|
4
|
3
|
2
|
1
|
0
|
24
|
4
|
3
|
2
|
5
|
6
|
58
|
21
|
8
|
13
|
|
| Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
2
|
3
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
|
| Total Current Assets |
16
|
3
|
9
|
0
|
6
|
5
|
4
|
1
|
0
|
0
|
24
|
5
|
4
|
4
|
5
|
6
|
60
|
23
|
8
|
24
|
|
| PP&E Net |
3
|
8
|
5
|
7
|
8
|
6
|
6
|
4
|
0
|
0
|
38
|
56
|
59
|
170
|
157
|
189
|
238
|
287
|
294
|
337
|
|
| PP&E Gross |
3
|
8
|
5
|
7
|
8
|
6
|
6
|
4
|
0
|
0
|
38
|
56
|
59
|
170
|
157
|
189
|
238
|
287
|
294
|
337
|
|
| Accumulated Depreciation |
0
|
9
|
18
|
19
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
56
|
73
|
73
|
49
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
|
| Total Assets |
19
N/A
|
11
-42%
|
14
+21%
|
8
-44%
|
14
+85%
|
11
-22%
|
9
-14%
|
5
-42%
|
0
N/A
|
0
N/A
|
62
N/A
|
60
-3%
|
64
+6%
|
174
+174%
|
162
-7%
|
195
+20%
|
298
+53%
|
310
+4%
|
305
-2%
|
365
+20%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
6
|
3
|
1
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
7
|
9
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
7
|
5
|
9
|
8
|
1
|
0
|
|
| Total Current Liabilities |
1
|
1
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
13
|
7
|
6
|
25
|
20
|
9
|
19
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
17
|
13
|
19
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
0
|
6
|
13
|
|
| Total Liabilities |
1
N/A
|
1
+19%
|
3
+102%
|
3
-13%
|
0
-83%
|
0
-17%
|
0
-31%
|
0
-9%
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+175%
|
0
-46%
|
13
+3 912%
|
7
-44%
|
6
-14%
|
59
+863%
|
37
-36%
|
28
-26%
|
52
+86%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
0
|
0
|
4
|
4
|
4
|
8
|
9
|
10
|
11
|
12
|
13
|
15
|
|
| Retained Earnings |
0
|
10
|
19
|
21
|
22
|
27
|
28
|
25
|
0
|
0
|
37
|
38
|
47
|
10
|
27
|
31
|
37
|
35
|
68
|
71
|
|
| Additional Paid In Capital |
18
|
19
|
29
|
24
|
33
|
35
|
34
|
28
|
0
|
0
|
95
|
95
|
107
|
164
|
174
|
209
|
265
|
298
|
334
|
372
|
|
| Other Equity |
0
|
0
|
0
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
3
|
4
|
|
| Total Equity |
18
N/A
|
10
-46%
|
11
+9%
|
5
-53%
|
14
+171%
|
11
-22%
|
9
-13%
|
5
-43%
|
0
N/A
|
0
N/A
|
62
N/A
|
60
-3%
|
63
+6%
|
161
+155%
|
155
-4%
|
189
+22%
|
239
+27%
|
272
+14%
|
277
+2%
|
313
+13%
|
|
| Total Liabilities & Equity |
19
N/A
|
11
-42%
|
14
+21%
|
8
-44%
|
14
+85%
|
11
-22%
|
9
-14%
|
5
-42%
|
0
N/A
|
0
N/A
|
62
N/A
|
60
-3%
|
64
+6%
|
174
+174%
|
162
-7%
|
195
+20%
|
298
+53%
|
310
+4%
|
305
-2%
|
365
+20%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
16
|
16
|
40
|
40
|
102
|
102
|
102
|
102
|
0
|
0
|
215
|
215
|
237
|
557
|
605
|
693
|
768
|
907
|
961
|
1 143
|
|